BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16885167)

  • 1. Proteinase-activated receptors, targets for kallikrein signaling.
    Oikonomopoulou K; Hansen KK; Saifeddine M; Tea I; Blaber M; Blaber SI; Scarisbrick I; Andrade-Gordon P; Cottrell GS; Bunnett NW; Diamandis EP; Hollenberg MD
    J Biol Chem; 2006 Oct; 281(43):32095-112. PubMed ID: 16885167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).
    Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Blaber M; Blaber SI; Scarisbrick I; Diamandis EP; Hollenberg MD
    Biol Chem; 2006 Jun; 387(6):817-24. PubMed ID: 16800746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin.
    Al-Ani B; Saifeddine M; Wijesuriya SJ; Hollenberg MD
    J Pharmacol Exp Ther; 2002 Feb; 300(2):702-8. PubMed ID: 11805236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
    Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
    Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
    Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue.
    Saifeddine M; al-Ani B; Cheng CH; Wang L; Hollenberg MD
    Br J Pharmacol; 1996 Jun; 118(3):521-30. PubMed ID: 8762073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells.
    Hwa JJ; Ghibaudi L; Williams P; Chintala M; Zhang R; Chatterjee M; Sybertz E
    Circ Res; 1996 Apr; 78(4):581-8. PubMed ID: 8635215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia.
    Knecht W; Cottrell GS; Amadesi S; Mohlin J; Skåregärde A; Gedda K; Peterson A; Chapman K; Hollenberg MD; Vergnolle N; Bunnett NW
    J Biol Chem; 2007 Sep; 282(36):26089-100. PubMed ID: 17623652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of recombinant trypsin isoforms on human proteinase-activated receptors (PAR): mesotrypsin cannot activate epithelial PAR-1, -2, but weakly activates brain PAR-1.
    Grishina Z; Ostrowska E; Halangk W; Sahin-Tóth M; Reiser G
    Br J Pharmacol; 2005 Dec; 146(7):990-9. PubMed ID: 16231009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.
    Ramachandran R; Hollenberg MD
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S263-82. PubMed ID: 18059329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiology and pathophysiology of proteinase-activated receptors (PARs): proteinases as hormone-like signal messengers: PARs and more.
    Hollenberg MD
    J Pharmacol Sci; 2005 Jan; 97(1):8-13. PubMed ID: 15665444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
    Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
    Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4.
    Quinton TM; Kim S; Derian CK; Jin J; Kunapuli SP
    J Biol Chem; 2004 Apr; 279(18):18434-9. PubMed ID: 14973136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.
    Steinhoff M; Buddenkotte J; Shpacovitch V; Rattenholl A; Moormann C; Vergnolle N; Luger TA; Hollenberg MD
    Endocr Rev; 2005 Feb; 26(1):1-43. PubMed ID: 15689571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.
    Hansen KK; Oikonomopoulou K; Li Y; Hollenberg MD
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):377-92. PubMed ID: 17952408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors.
    Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT
    Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of protease-activated receptor (PAR)-1, -2 and -4-activating peptides, thrombin and trypsin in rat isolated airways.
    Chow JM; Moffatt JD; Cocks TM
    Br J Pharmacol; 2000 Dec; 131(8):1584-91. PubMed ID: 11139435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2).
    Ramachandran R; Mihara K; Chung H; Renaux B; Lau CS; Muruve DA; DeFea KA; Bouvier M; Hollenberg MD
    J Biol Chem; 2011 Jul; 286(28):24638-48. PubMed ID: 21576245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells.
    Hansen KK; Saifeddine M; Hollenberg MD
    Immunology; 2004 Jun; 112(2):183-90. PubMed ID: 15147561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypsin- and SLIGRL-induced vascular relaxation and the inhibition by benzamidine derivatives.
    Glusa E; Saft A; Prasa D; Stürzebecher J
    Thromb Haemost; 1997 Nov; 78(5):1399-403. PubMed ID: 9408026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.